Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 81 of 81 found
From 9 References


Hu et al 2018, Nucleic Acids Res
  Squamous cell carcinoma Unknown site
AKR1A1/AGO3
t(1;1)(p34;p34)
  Squamous cell carcinoma Unknown site
CCDC23/EBNA1BP2
t(1;1)(p34;p34)
  Squamous cell carcinoma Uterus, cervix
CCDC24/ST3GAL3
t(1;1)(p34;p34)
  Adenocarcinoma Stomach
CTPS1/NFYC
t(1;1)(p34;p34)
  Adenocarcinoma Uterus, corpus
ERI3/EIF2B3
t(1;1)(p34;p34)
  Mesenchymal tumor, NOS Unknown site
EXO5/MTF1
t(1;1)(p34;p34)
  Malignant epithelial tumor, special type Uterus, corpus
FOXJ3/ZMYND12
t(1;1)(p34;p34)
  Adenocarcinoma Prostate
GPBP1L1/ZMPSTE24
t(1;1)(p34;p34)
  Adenocarcinoma Large intestine
IPO13/EIF2B3
t(1;1)(p34;p34)
  Adenocarcinoma Oesophagus
KDM4A/MPL
t(1;1)(p34;p34)
  Squamous cell carcinoma Lung
KDM4A/PTCH2
t(1;1)(p34;p34)
  Squamous cell carcinoma Uterus, cervix
KIF2C/C1orf228
t(1;1)(p34;p34)
  Adenocarcinoma Stomach
MACF1/FOXJ3
t(1;1)(p34;p34)
  Squamous cell carcinoma Lung
MACF1/RHBDL2
t(1;1)(p34;p34)
  Squamous cell carcinoma Lung
MACF1/INPP5B
t(1;1)(p34;p34)
  Adenocarcinoma Uterus, corpus
MAP7D1/AGO3
t(1;1)(p34;p34)
  Adenocarcinoma Uterus, corpus
MAST2/MMACHC
t(1;1)(p34;p34)
  Adenocarcinoma Prostate
MAST2/ST3GAL3
t(1;1)(p34;p34)
  Adenocarcinoma Large intestine
MAST2/C1orf228
t(1;1)(p34;p34)
  Adenocarcinoma Breast
MED8/SCMH1
t(1;1)(p34;p34)
  Adenocarcinoma Prostate
NASP/PIK3R3
t(1;1)(p34;p34)
  Mesenchymal tumor, NOS Unknown site
PABPC4/MACF1
t(1;1)(p34;p34)
  Malignant melanoma Skin
PPIH/CCDC30
t(1;1)(p34;p34)
  Malignant epithelial tumor, special type Uterus, corpus
PPT1/HIVEP3
t(1;1)(p34;p34)
  Adenocarcinoma Breast
RLF/SFPQ
t(1;1)(p34;p34)
  Malignant epithelial tumor, special type Uterus, corpus
RRAGC/RHBDL2
t(1;1)(p34;p34)
  Adenocarcinoma Breast
SCMH1/AGO3
t(1;1)(p34;p34)
  Adenocarcinoma Prostate
SCMH1/MACF1
t(1;1)(p34;p34)
  Malignant epithelial tumor, special type Uterus, corpus
SF3A3/HPCAL4
t(1;1)(p34;p34)
  Squamous cell carcinoma Lung
SH3D21/THRAP3
t(1;1)(p34;p34)
  Adenocarcinoma Stomach
SH3D21/AGO3
t(1;1)(p34;p34)
  Adenocarcinoma Lung
SLC6A9/EIF2B3
t(1;1)(p34;p34)
  Adenocarcinoma Oesophagus
ST3GAL3/PTPRF
t(1;1)(p34;p34)
  Adenocarcinoma Breast
ST3GAL3/KDM4A
t(1;1)(p34;p34)
  Adenocarcinoma Uterus, corpus
ST3GAL3/TIE1
t(1;1)(p34;p34)
  Mesenchymal tumor, NOS Unknown site
STK40/OSCP1
t(1;1)(p34;p34)
  Adenocarcinoma Lung
THRAP3/ERI3
t(1;1)(p34;p34)
  Adenocarcinoma Kidney
THRAP3/TRAPPC3
t(1;1)(p34;p34)
  Adenocarcinoma Kidney
TRIT1/MFSD2A
t(1;1)(p34;p34)
  Adenocarcinoma Large intestine
ZMPSTE24/TMCO2
t(1;1)(p34;p34)
  Germ cell tumor, NOS Testis
ZNF684/EIF2B3
t(1;1)(p34;p34)

Iwakawa et al 2013, Genes Chromosomes Cancer
  Undifferentiated carcinoma, small cell Lung
RLF/MYCL
t(1;1)(p34;p34)
  Undifferentiated carcinoma, small cell Lung
RLF/COL9A2
t(1;1)(p34;p34)
  Undifferentiated carcinoma, small cell Lung
RLF/SMAP2
t(1;1)(p34;p34)
  Undifferentiated carcinoma, small cell Lung
CAP1/MACF1
t(1;1)(p34;p34)
  Undifferentiated carcinoma, small cell Lung
ZMPSTE24/MFSD2A
t(1;1)(p34;p34)
  Undifferentiated carcinoma, small cell Lung
SF3A3/GNL2
t(1;1)(p34;p34)
  Undifferentiated carcinoma, small cell Lung
SMAP2/MYCL
t(1;1)(p34;p34)

Kim et al 2014, Oncogene
  Adenocarcinoma Stomach
IPP/GPBP1L1
t(1;1)(p34;p34)

Kim et al 2015, Genes Chromosomes Cancer
  Adenocarcinoma Breast
PRDX1/AKR1A1
t(1;1)(p34;p34)

Nik-Zainal et al 2016, Nature
  Adenocarcinoma Breast
RNF220/MAST2
t(1;1)(p34;p34)

Rudin et al 2012, Nat Genet
  Undifferentiated carcinoma, small cell Lung
INPP5B/SF3A3
t(1;1)(p34;p34)

Sato et al 2013, Nat Genet
  Adenocarcinoma Kidney
ZMYM4/PSMB2
t(1;1)(p34;p34)

Wen et al 2012, PLoS One
  Acute myeloid leukemia, NOS
PPCS/CCDC30
t(1;1)(p34;p34)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Ovary
FOXJ3/CCDC23
t(1;1)(p34;p34)
  Adenocarcinoma Ovary
RLF/MFSD2A
t(1;1)(p34;p34)
  Adenocarcinoma Lung
EPHA10/COL8A2
t(1;1)(p34;p34)
  Adenocarcinoma Lung
SZT2/EIF2B3
t(1;1)(p34;p34)
  Adenocarcinoma Lung
AKIRIN1/MEAF6
t(1;1)(p34;p34)
  Adenocarcinoma Lung
P3H1/ERI3
t(1;1)(p34;p34)
  Adenocarcinoma Lung
THRAP3/AGO3
t(1;1)(p34;p34)
  Squamous cell carcinoma Oral cavity
MACF1/AKIRIN1
t(1;1)(p34;p34)
  Squamous cell carcinoma Oral cavity
PIK3R3/ZSWIM5
t(1;1)(p34;p34)
  Adenocarcinoma Breast
PIK3R3/LRRC41
t(1;1)(p34;p34)
  Adenocarcinoma Breast
PTPRF/HIVEP3
t(1;1)(p34;p34)
  Adenocarcinoma Breast
SCMH1/GPBP1L1
t(1;1)(p34;p34)
  Astrocytoma, grade III-IV/Glioblastoma Brain
MTF1/SF3A3
t(1;1)(p34;p34)
  Adenocarcinoma Breast
SCMH1/EIF2B3
t(1;1)(p34;p34)
  Adenocarcinoma Breast
THRAP3/MAP7D1
t(1;1)(p34;p34)
  Adenocarcinoma Breast
MACF1/GRIK3
t(1;1)(p34;p34)
  Adenocarcinoma Breast
SCMH1/PPT1
t(1;1)(p34;p34)
  Adenocarcinoma Breast
THRAP3/MUTYH
t(1;1)(p34;p34)
  Adenocarcinoma Breast
HEYL/COL9A2
t(1;1)(p34;p34)
  Adenocarcinoma Breast
TMEM53/EIF2B3
t(1;1)(p34;p34)
  Adenocarcinoma Breast
KDM4A/HYI
t(1;1)(p34;p34)
  Adenocarcinoma Breast
PTPRF/GUCA2A
t(1;1)(p34;p34)
  Adenocarcinoma Breast
EIF2B3/HYI
t(1;1)(p34;p34)
  Adenocarcinoma Breast
ZMYM4/UTP11L
t(1;1)(p34;p34)
  Adenocarcinoma Breast
MAST2/NASP
t(1;1)(p34;p34)
  Adenocarcinoma Breast
KDM4A/PTPRF
t(1;1)(p34;p34)
  Transitional cell carcinoma Bladder
HIVEP3/ZMYND12
t(1;1)(p34;p34)